NORTHERN TRUST CORP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 212 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$1,660,400
-57.6%
488,353
-8.4%
0.00%
-100.0%
Q2 2023$3,918,248
-29.3%
533,095
-0.4%
0.00%0.0%
Q1 2023$5,545,678
-43.6%
535,297
-35.7%
0.00%
-50.0%
Q4 2022$9,836,100
-44.4%
832,862
-1.1%
0.00%
-50.0%
Q3 2022$17,676,000
-5.1%
842,130
+40.3%
0.00%0.0%
Q2 2022$18,633,000
-26.3%
600,318
-2.6%
0.00%0.0%
Q1 2022$25,294,000
+4.5%
616,032
+10.6%
0.00%0.0%
Q4 2021$24,204,000
-47.5%
556,771
-39.5%
0.00%
-50.0%
Q3 2021$46,100,000
-22.2%
920,734
-2.1%
0.01%
-20.0%
Q2 2021$59,257,000
-17.4%
940,733
+21.8%
0.01%
-23.1%
Q1 2021$71,766,000
-0.3%
772,431
-3.8%
0.01%
-7.1%
Q4 2020$71,980,000
-12.8%
803,336
+0.6%
0.01%
-22.2%
Q3 2020$82,529,000
+36.7%
798,696
+4.6%
0.02%
+28.6%
Q2 2020$60,366,000
-1.7%
763,355
-28.1%
0.01%
-22.2%
Q1 2020$61,428,000
+10.1%
1,061,674
+2.6%
0.02%
+50.0%
Q4 2019$55,816,000
-0.1%
1,034,592
-3.2%
0.01%
-7.7%
Q3 2019$55,851,000
+15.4%
1,068,297
+6.7%
0.01%
+18.2%
Q2 2019$48,378,000
+6.1%
1,001,419
+11.0%
0.01%0.0%
Q1 2019$45,597,000
-11.2%
902,561
+4.2%
0.01%
-21.4%
Q4 2018$51,371,000
-19.9%
866,570
-11.0%
0.01%
-12.5%
Q3 2018$64,121,000
+10.4%
974,036
-15.3%
0.02%
+6.7%
Q2 2018$58,072,000
+6.8%
1,150,184
+11.3%
0.02%
+7.1%
Q1 2018$54,392,000
+13.2%
1,033,086
-0.1%
0.01%
+16.7%
Q4 2017$48,038,000
+14.0%
1,033,732
-0.7%
0.01%
+9.1%
Q3 2017$42,124,000
+37.0%
1,041,385
+14.9%
0.01%
+22.2%
Q2 2017$30,747,000
+71.9%
906,731
+47.2%
0.01%
+80.0%
Q1 2017$17,885,000
-8.8%
615,868
+3.1%
0.01%
-16.7%
Q4 2016$19,619,000
+13.0%
597,406
+8.5%
0.01%
+20.0%
Q3 2016$17,361,000
+15.4%
550,649
+3.0%
0.01%0.0%
Q2 2016$15,038,000
-16.1%
534,798
+8.3%
0.01%
-16.7%
Q1 2016$17,932,000
-7.6%
493,659
+1.8%
0.01%0.0%
Q4 2015$19,406,000
+38.6%
485,023
-1.3%
0.01%
+20.0%
Q3 2015$14,001,000
+2.5%
491,448
+18.6%
0.01%
+25.0%
Q2 2015$13,658,000
+32.1%
414,485
+15.3%
0.00%
+33.3%
Q1 2015$10,339,000
+8.8%
359,503
+3.0%
0.00%0.0%
Q4 2014$9,507,000
+24.6%
349,101
-2.5%
0.00%
+50.0%
Q3 2014$7,628,000
-4.6%
357,952
+0.5%
0.00%0.0%
Q2 2014$7,996,000
-19.8%
356,014
-9.8%
0.00%
-33.3%
Q1 2014$9,975,000
+2.5%
394,774
-6.7%
0.00%0.0%
Q4 2013$9,731,000
+19.4%
423,244
-1.0%
0.00%0.0%
Q3 2013$8,147,000
+34.0%
427,671
+1.4%
0.00%
+50.0%
Q2 2013$6,082,000421,7760.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders